Serum leucine aminopeptidase (LAP), as measured by the method of Goldbarg and Rutenburg (1) , is elevated in patients with biliary cirrhosis, intrahepatic cholestasis, metastatic carcinoma of the liver, carcinoma of the pancreas obstructing the common bile duct or metastatic to the liver, carcinoma of the biliary tree, primary hepatoma, infiltrative diseases of the liver such as lymphoma, sarcoidosis, and so forth, and infectious hepatitis (2, 3) .
In order further to compare serum LAP activity in normal subjects and in patients with a variety of diseases involving the pancreas, liver and biliary tree, its mobility was measured by starch gel electrophoresis. Although there was a common peak of activity in the sera of both normal subj ects and of patients with the diseases studied, LAP was also noted at other sites in the latter group.
MATERIALS AND METHODS
All sera were obtained from fasting, normal healthy subjects and from patients on the medical and surgical wards of The New York Hospital, whose diagnoses were confirmed either by biopsy, surgical exploration, autopsy, or by their clinical courses.
The study group included 8 normal adults and 36 patients with a variety of inflammatory, malignant, and granulomatous diseases affecting the liver, biliary tract, and/or the pancreas. There were 6 patients with primary biliary cirrhosis; 6 with acute infectious hepatitis; 5 with Laennec's cirrhosis and acute fatty infiltration of the liver; 1 with lymphosarcoma involving the liver; 1 with sarcoidosis; 2 with Hodgkin's disease; 4 with carcinoma of the colon, metastatic to the liver; 2 with common duct stone; 1 with toxic hepatitis secondary to Mitomycin; and 1 with infectious mononucleosis. Seven patients with carcinoma of the pancreas were also-studied (Table I ). In 6 the tumor was in the head of the pancreas. Of these, 2 had obstruction of the common * This work was supported by Research Grant CS-9386 from the National Institutes of Health, Bethesda, Md.
bile duct but no metastases to the liver; 2 had no obstruction but had hepatic metastases; and 2 had neither obstruction nor metastases. One patient's lesion was in the body and tail of the pancreas but was metastatic to the liver. This individual, however, had no common duct obstruction.
All of the patients had elevated levels of serum LAP, except the two with carcinoma of the head of the pancreas with neither common duct obstruction nor metastases to the liver. Three patients with viral hepatitis and two with cirrhosis and fatty infiltration were studied serially and upon recovery, when the elevated serum LAP had fallen to normal. Serum proteins were separated by zone electrophoresis according to a modification of the starch gel method of Smithies (4), reported by Pert, Sleisenger, Woods and Engle (5). Electrophoresis was carried out at 12°C at 4.5 v per cm for 16 hours. In early experiments electrophoresis was performed using starch gel strips 2 cm wide. After completion of the electrophoretic run, the gels were scored in 0.5 cm sections and cut in half along the horizontal plane. One half was retained for protein staining with a saturated solution of naphthalene black 12B 200 (4), and the second half was cut in 0.5 cm sections which were placed directly in tubes containing the necessary amount of buffered substrate for the determination of LAP by the method of Goldbarg and Rutenburg, at pH 7.1 utilizing a chromogenic substrate, L-leucyl-p-naphthylamide hydrochloride. The ,-naphthylamine liberated by enzymatic hydrolysis was assayed by a modified Bratton-Marshall reaction (1). Activity under each major peak was expressed as percentage of the sum total of all 0.5 cm sections of the gel strips (Table I) .
In later experiments, when information was needed regarding the amount of protein present in each 0.5 cm section, starch gel strips, 4.5 cm wide, were used. The serum protein was separated by zone electrophoresis in a similar manner. The strips were scored in 0.5 cm sections but were divided in half vertically before being halved along the horizontal plane. One-fourth of the gel was retained for protein staining. In the remaining three-fourths, corresponding 0.5 cm sections of the gel were placed in separate tubes containing 3 ml of water, mechanically sha.; ni for 30 minutes at room temperature, and eluates of each 0.5 cm section were recovered. The eluates were then filtered and 0. Rosebrough, Farr and Randall (6) , and compared with a bovine albumin standard. One ml of the filtrate was used for the determination of LAP.
LAP activity is plotted against the distances per 0.5 cm migrated (cross-hatched bars; Figures 1-3, 6 ). Similarly, electrophoresis, protein assays, and LAP determinations were performed on specimens of ascitic fluid, pleural fluid, bile obtained from patients by T-tube drainage of the common duct and by peroral duodenal intubation, 1 per cent pancreatic extract (Organon), and mixtures of the latter two substances with normal and abnormal sera.
RESULTS
The starch gel electrophoretic patterns showed that in all instances the major zone of LAP activity coincided exactly with the postalbumin fraction of serum or lay in the region of the fast a2 and postalbumin fractions. In 34 pathological sera there was significant activity in the region between the origin and slow a2, and in 27 of these specimens a peak of activity was also found in the regiQn of the slow a2 and ,8-globulin fractions.
The area labeled origin to slow a2 does not stain with the protein stain used in our experiments, but it can be seen that there is a large amount of protein present as measured by the microprotein determination (Figures 4, 5) . Table I summarizes the results obtained from 54 specimens and includes the diagnosis, the nature of specimen studied, the number of peaks of LAP found and the activity of each peak expressed as percentage of the sum total of all 0.5 cm sections of the gel.
Normal subjects. In the sera of all eight normal subjects, there was one peak of LAP activity. In six specimens this peak coincided exactly with the postalbumin fraction of serum, but in two instances it lay in the region of the fast a2 and postalbumin (Figure 1) (Figures 1, 2 ). When these fluids were diluted with sera having elevated LAP activity, all peaks of LAP activity were preserved and the postalbumin peak or the peak coinciding with the fast a2 and postalbumin was augmented. LAP activity similar to those in the patients with acute infectious hepatitis, the predominant activity lying in the postalbumin fraction or in the region of the fast a2 and postalbumin (Figure 4) .
Two peaks of LAP activity were noted in one patient with intrahepatic cholestasis associated with Mitomycin therapy and in six patients with primary biliary cirrhosis, the predominant one residing in the normal fractions and the other in the region between the origin and slow a., (Figure 5) .
Upon complete clinical and biochemical recovery of three patients with acute hepatitis and of two patients with fatty infiltration of the liver, repeat studies demonstrated only the single normal peak of LAP activity (Figure 3) . A similar observation was made in two patients with common duct stone, who demonstrated a single normal peak of LAP activity after. removal of the calculus ( Figure 6 ). :The disappearance of two peaks upon curie of these-conditions also coincided with the fall of'-serum LAP to normal.
DISCUSSION
Leucine aminopeptidase activity of normal serum, measured at pH 7.1, appears as a single peak with an electrophoretic mobility on starch gel which coincides with the postalbumin fraction of serum or the fast a2 and postalbumin fractions. Bile, pancreatic extract (Organon), and mixtures of these substances with normal serum likewise demonstrated a single peak of LAP activity similar to that found in normal serum. The similarity of electrophoretic mobility of LAP from serum and bile and the histochemical localization of LAP in bile canaliculi (7) strongly suggest that these structures are the source of both serum and bile LAP which migrate with the postalbumin fraction or the fast a2 and postalbumin fractions. The possibility that the reverse is true, namely, that bile LAP is derived from serum, cannot be excluded.
The presence of two additional peaks of LAP activity in patients with either parenchymal or metastatic liver disease and their disappearance from the sera of those patients who have had clinical and biochemical recovery from infectious hepatitis and fatty infiltration of the liver is consistent with the possibility that LAP in the regions of origin to slow a, and a2 to pl-globulin is derived from the liver. However, their disappearance following relief of common bile duct obstruction, leaving the single normal peak. also indicates that stasis may alter LAP.
It is noteworthy that the electrophoretic mobility of serum LAP in two patients with carcinoma of the head of the pancreas was similar to that in normal subjects. Neither patient had jaundice or metastasis to the liver, and the total serum LAP activity in each was normal. In contrast, in patients with carcinoma of the head or body and tail of the pancreas who had either common duct obstruction or metastases to the liver, the serum LAP was elevated. Further, such patients demonstrated three peaks of LAP activity by starch gel electrophoresis. This finding is not specific for carcinoma of the pancreas since it was observed in four patients with carcinoma of the colon with metastases to the liver and in two patients with choledocholithiasis ( Figures  4, 6 ).
These findings suggest that neither elevation nor electrophoretic alteration of serum LAP is specific for carcinoma of the pancreas; rather they support the hypothesis that such changes are dependent upon common bile duct obstruction or metastasis to the liver. SUMMARY 1. The electrophoretic mobility of leucine aminopeptidase (LAP) of normal serum, sera of patients with pancreatic and hepatobiliary disease, bile, pleural fluid and pancreatic extract has been determined by starch gel electrophoresis.
2. There is a single peak of activity in normal serum identical with that of bile and pancreatic extract, located in the postalbumin fraction or in the fast a, and postalbumin areas.
3. Two additional peaks of LAP activity are found in the sera of patients with parenchymal or metastatic liver disease and with common bile duct obstruction. With recovery of liver disease or relief of obstruction, these peaks disappear.
4. Electrophoretic mobility of serum LAP in patients with carcinoma of the pancreas is normal, unless there is common duct obstruction or metastasis to the liver.
